Cited by 140Alzheimer's disease research and treatmentsMedicinal Plants and NeuroprotectionCholinesterase and Neurodegenerative Diseases

Can herbs provide a new generation of drugs for treating Alzheimer’s disease?

Anekonda, Thimmappa S., Reddy, P. Hemachandra·2005·Brain Research Reviews

Abstract

The overall aim of this review is to discuss cellular mechanisms at work in the progression of AD and current therapeutic strategies for treating AD, with a focus on the potential efficacy of herbal treatments. Recent advances in molecular, cellular, and animal model studies have revealed that formation of the 4-kDa amyloid beta peptide is a key factor in the development and progression of AD. Several cellular changes have been identified that are related to amyloid beta plaques and neurofibrillary tangles found in the autopsied brains of AD patients and in AD animal models. Several therapeutic strategies have been developed to treat AD, including anti-inflammatory, anti-oxidant, and anti-amyloid approaches. Recently, herbal treatments have been tested in animal and cellular models of AD and in clinical trials with AD subjects. In AD animal models and cell models, herbal extracts appear to have fewer adverse effects than beneficial effects on A beta and cognitive functions. These extracts have multi-functional properties (pro-cholinergic, anti-oxidant, anti-amyloid, and anti-inflammatory), and their use in the treatment of AD patients looks promising. The chemical compositions of herbs and their potential for alleviating or reducing symptoms of AD or for affecting the disease mechanism need to be further studied.

Integrity signals

Registry

Crossref · 10.1016/j.brainresrev.2005.09.001

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

8 of the 176 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Anekonda, T. S., & Reddy, P. H.
Affiliations
Oregon Health & Science University (US)
Corresponding author
Reddy, P. Hemachandra
Venue
Brain Research Reviews
Publisher
Elsevier BV
Published
2005-12
Volume
50
Issue
2
Pages
361-376
ISSN
0165-0173 (ISSN-L)
OpenAlex
W1991124307
Cited by
140
References
176
Citations by year
2026: 1 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 11 · 2019: 12 · 2018: 8 · 2017: 6 · 2016: 9 · 2015: 8 · 2014: 10 · 2013: 10 · 2012: 6
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Locations
  • Brain Research Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1r03ag022643-01)
  • National Institute on Aging (AG 22643)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
Keywords
Alzheimer's disease, herbal medicine, amyloid-beta, amyloid plaques, neurofibrillary tangles, anti-amyloid therapy, anti-inflammatory therapy, antioxidant therapy, cognitive function, plant extracts, animal models of Alzheimer's disease
MeSH terms
Alzheimer Disease, Animals, Antioxidants, Disease Models, Animal, Humans, Plant Extracts, Herbal Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review